The post HBAR Weekly Analysis Mar 22 appeared on BitcoinEthereumNews.com. HBAR closed the week with a %4,23 decline, continuing its downward trend, while tryingThe post HBAR Weekly Analysis Mar 22 appeared on BitcoinEthereumNews.com. HBAR closed the week with a %4,23 decline, continuing its downward trend, while trying

HBAR Weekly Analysis Mar 22

2026/03/23 07:20
Okuma süresi: 4 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen crypto.news@mexc.com üzerinden bizimle iletişime geçin.

HBAR closed the week with a %4,23 decline, continuing its downward trend, while trying to hold above the critical support level of $0.0870. Although market structure shows distribution phase signals, a cautious strategy should be prioritized due to BTC correlation and weakening momentum.

HBAR in the Weekly Market Summary

HBAR completed the week at its current price of $0.09 with a %4,23 decline and got stuck around $0.09 as the overall trading range narrowed. The volume profile remained low at the $75.71M level, while the primary trend was confirmed as downward. RSI at 37.76 is in the neutral-bearish zone, MACD shows a negative histogram, and the price is trading below EMA20 ($0.10). In this context, the market is positioned in a consolidation and potential test phase in the bigger picture. For portfolio managers, short-term selling pressure may maintain dominance unless the trend structure breaks. You can check the link for detailed HBAR spot analysis.

Trend Structure and Market Phases

Long-Term Trend Analysis

Market structure shows that HBAR remains within its long-term downtrend. On higher timeframes (weekly and monthly), the price continues to stay below exponential moving averages, and negative momentum indicators confirm the trend’s strength. Positioned near the lower band of the main descending channel, HBAR requires a strong catalyst to reach the $0.1215 upside target, while the current structure indicates a distribution phase. The trend remains persistently downward; if the $0.0870 support breaks, deeper corrections may come into play. In this phase, patience and level-focused management are critically important for position traders.

Accumulation/Distribution Analysis

Volume profile and price action have exhibited distribution patterns in recent weeks: low-volume declines and rejections from resistances dominate. However, with RSI declining to 37.76, oversold signals are beginning to emerge, increasing the possibility of an accumulation phase starting around $0.0870. Distribution characteristics – high-volume sales and upper shadow formations – remain dominant; volume increase and holding are required for accumulation. Market phase transition should be confirmed with multi-timeframe confluence. You can gain additional insights from the HBAR and other analyses page.

Multi-Timeframe Confluence

Daily Chart View

On the daily timeframe, HBAR shows a bearish bias with 3 support and 2 resistance levels (total 11 strong levels). The price pulled back without testing the $0.0942 resistance and got stuck in the $0.0899-$0.0870 corridor. The MACD histogram is expanding negatively, and closes below EMA20 support trend breakdown. Critical confluence: $0.0870 support overlaps with the daily pivot (score 74/100). For an upside breakout, a close above $0.0942 is required; otherwise, downside accelerates.

Weekly Chart View

The weekly chart emphasizes downtrend dominance with 1 support and 3 resistances (2 resistances on 3D timeframe). The price was rejected without approaching the weekly EMA50 (around $0.10) and negative divergence patterns are forming. The lower band of the long-term channel ($0.0834) may be tested; if it holds, the sideways phase extends. Confluence aligns with bearish filter: resistance superiority across all timeframes.

Critical Decision Points

Main supports: $0.0870 (74/100), $0.0834 (61/100), $0.0793 (64/100). A break of these levels triggers $0.0551 downside risk. Resistances: $0.0942 (82/100), $0.0899 (61/100); $0.10 EMA20 confluence is the main inflection point. Trend structure remains intact above $0.0870; on breakdown, aggressive bearish scenario activates. Strategic R/R ratio is near 1:2 with upside $0.1215 against downside $0.0551 – ideal for risk management.

Weekly Strategy Recommendation

In Case of Rise

A close above $0.0942 and EMA20 $0.10 breakout activates the bullish scenario: first target $0.1215, stop-loss below $0.0870. Position size should be limited to %1-2 risk. If supported by BTC stabilization, accumulation phase begins and long positions can be accumulated. Evaluate futures contracts for HBAR futures market data.

In Case of Decline

A $0.0870 breakdown creates a short opportunity: targets $0.0834, $0.0793, and $0.0551. Stop-loss above $0.0942. While distribution phase continues, hedge strategies (paired with BTC short) are recommended in the portfolio. For bottom hunting in extreme decline, wait for RSI <30.

Bitcoin Correlation

HBAR exhibits high correlation with BTC (%0.85+); BTC’s downtrend at $68,372 level (testing $68,116 support) increases selling pressure in altcoins. BTC Supertrend bearish signal is a caution flag for HBAR: if BTC slips below $66,201, HBAR challenges $0.0793. BTC levels to watch: supports $68,116/$66,201, resistances $68,934/$70,612. HBAR bullish bias remains weak without BTC recovery – ideal setup for correlation trades.

Conclusion: Key Points for Next Week

Next week’s focus: $0.0870 hold vs. breakdown, BTC $68k band reaction, and volume increase. Bullish confluence above $0.0942+, bearish below $0.0870-. In macro silence, technical structures will guide; position traders should stay level-based. Weekly closes are critical for trend confirmation.

This analysis uses the market views and methodology of Chief Analyst Devrim Cacal.

Trading Analyst: Emily Watson

Short-term trading strategies expert

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/hbar-technical-analysis-march-22-2026-weekly-strategy

Piyasa Fırsatı
Hedera Logosu
Hedera Fiyatı(HBAR)
$0,08969
$0,08969$0,08969
+0,04%
USD
Hedera (HBAR) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Supported by hike speculation and PMIs – Danske Bank

Supported by hike speculation and PMIs – Danske Bank

The post Supported by hike speculation and PMIs – Danske Bank appeared on BitcoinEthereumNews.com. Danske Research Team points out that the Euro was the second-
Paylaş
BitcoinEthereumNews2026/03/23 15:59
The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The World Bank’s debarment of PwC and EY for fraud in Ethiopia and Somalia has lifted the veil on the fragility of the Western development model, creating a strategic
Paylaş
Theexchange2026/03/23 16:33
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Paylaş
BitcoinEthereumNews2025/09/18 03:11